TENDO AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.124 SEK | -0.80% |
|
-0.80% | -79.33% |
| 20/05 | Tendo AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 15/01 | Tendo AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 52.79L 5L 4.18Cr | Sales 2023 | 61.44L 6L 4.87Cr | Capitalization | 68.85L 7L 5.46Cr |
|---|---|---|---|---|---|
| Net income 2022 | -40L -4L -3.17Cr | Net income 2023 | -80L -8L -6.34Cr | EV / Sales 2022 | 2.55 x |
| Net cash position 2022 | 66.7L 6L 5.29Cr | Net cash position 2023 | 10.55L 1L 83.61L | EV / Sales 2023 | 0.95 x |
| P/E ratio 2022 |
-3.75
x | P/E ratio 2023 |
-0.76
x | Employees | 7 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.80% | ||
| 1 week | -0.80% | ||
| 1 month | -27.06% | ||
| 3 months | -71.16% | ||
| 6 months | -74.17% | ||
| Current year | -79.33% |
1 week
0.11
0.13
1 month
0.110.22
Current year
0.111.90
1 year
0.111.90
3 years
0.116.60
5 years
0.116.60
10 years
0.116.60
| Managers | Title | Age | Since |
|---|---|---|---|
Sofie Woge
FOU | Founder | - | 01/16/01 |
Gunnar Telhammar
DFI | Director of Finance/CFO | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mette Gross
CHM | Chairman | 52 | 01/22/01 |
Peter Arndt
BRD | Director/Board Member | 57 | 01/22/01 |
Sofie Woge
FOU | Founder | - | 01/16/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 0.124 | -0.80% | 410,160 |
| 29/24/29 | 0.125 | +3.31% | 1,230,912 |
| 28/24/28 | 0.121 | +3.42% | 3,966,403 |
| 27/24/27 | 0.117 | -6.40% | 371,458 |
| 24/24/24 | 0.125 | -2.34% | 874,908 |
End-of-day quote NORDIC GROWTH MARKET, May 31, 2024
More quotes
Tendo AB is a Sweden-based medical technology company that develops medical technology robotic aids for spinal cord injury. The company's products mainly include Tendo OneGrip, a glove with a so-called integrated exoskeleton that assists people with limited hand function as a result of a spinal cord injury. The company works to give back independence to people living with a disability and at the same time contribute to solving the global health challenges. Tendo aims to operate sales of the product in countries with established national insurance schemes suitable for Tendo's business model. Denmark, where the Company has established collaborations with primarily orthopedic engineers, is considered to be the initial market, together with Sweden and Norway.
Calendar
20/08/2024
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -79.33% | 10.16L | |
| -7.16% | 18TCr | |
| -1.23% | 11TCr | |
| -4.86% | 6.7TCr | |
| -4.29% | 4.72TCr | |
| +10.32% | 4.46TCr | |
| +8.14% | 4.25TCr | |
| +15.76% | 3TCr | |
| +15.53% | 2.52TCr | |
| -5.88% | 2.41TCr |
- Stock Market
- Equities
- TENDO Stock
